As of 2025-07-14, the Fair Value of Jiangxi Fushine Pharmaceutical Co Ltd (300497.SZ) is -2.47 CNY. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 9.99 CNY, the upside of Jiangxi Fushine Pharmaceutical Co Ltd is -124.69%.
With the market price of 9.99 CNY and our fair value calculation, Jiangxi Fushine Pharmaceutical Co Ltd (300497.SZ) is not a good investment. Investing in 300497.SZ stocks now will result in a potential loss of 124.69%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | 319.30 | 48.83 | -141.47 | -200.80 | -272.10 | -49.25 |
| YoY growth | 4.41% | -84.71% | -389.72% | -41.94% | -35.51% | -109.49% |
| Market Cap (mil) | 5,494.50 |
| P/E | |
| Forward P/E |
| EPS | -0.49 |
| Avg earnings growth rate | -109.49% |
| TTM earnings | -271.33 |